宜通世紀(300310.SZ):擬以3100萬元認購創業投資基金 其主投5G產業鏈、新材料、醫療大健康等戰略新興產業
格隆匯7月30日丨宜通世紀(300310.SZ)公佈,公司為了更好地藉助專業機構的專業力量及資源優勢,發掘科技創新產業領域的優質初創企業,通過直接投資推動技術創新,在獲取財務利益的同時進一步拓展公司的業務領域,提高公司的綜合競爭力,近日,公司子公司宜通世紀(廣東)產業投資有限公司(“宜通產投”)與專業投資機構廣州科創國發產業基金管理有限公司(“科創國發”)、廣州智盛股權投資基金管理有限公司(“智盛投資”)開展合作,宜通產投以自有資金人民幣3100萬元出資認購由廣州科創國發產業基金管理有限公司發起設立的創業投資基金——廣州科創智匯二號創業投資合夥企業(有限合夥)(“合夥企業”、“創業投資基金”或“基金”)的有限合夥份額,投資領域:主要投資5G產業鏈、新材料、醫療大健康等戰略新興產業。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.